AzTrials
AzTrials

HydroceleNCT05617261

Evaluating Patient Tolerability and Success for Penile and Scrotal Urologic Procedures Under Conscious Sedation: A Prospective Study

An observational study of Hydrocele and Spermatocele, run by University of Manitoba at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to evaluate patient reported outcomes and tolerability of scrotal and penile urologic procedures under the administration of minimal conscious sedation. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Hydrocele, Spermatocele, Varicocele
What is being tested?
Conscious sedation
How many people
150 participants
Where
1 siteCanada
Study dates
13 Nov 2022to 1 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing: hydrocelectomy, spermatocelectomy, varicocelectomy, epididymectomy, testicular biopsy, adult circumcision, frenulectomy, penile plication, orchiectomy, and vasectomy reversal at the Manitoba Men's Health Clinic (Winnipeg, MB, Canada) will be approached for potential enrolment.

Who may be able to join

  • patients over the age of 18
  • undergoing one of the previously mentioned procedures under local anesthesia with or without conscious sedation
  • having a minimum follow-up of 4-6 weeks.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Men's Health Clinic Manitoba

    Winnipeg, Manitoba

Other trials in Canada

About this study

The goal of this observational study is to evaluate patient reported outcomes and tolerability of scrotal and penile urologic procedures under the administration of minimal conscious sedation. This will be assessed at 4-6 weeks post-procedure where patients will be followed up with a questionnaire assessing how well patients tolerated the procedure and if patients would opt for conscious sedation again in a similar, future procedure. The investigators will secondarily be assessing the associated cost savings as compared to having these procedures performed under general anesthesia at a tertiary care hospital.

Read the detailed description

Background:

The current standard of care for the vast majority of urological procedures is the administration of general anesthesia, spinal anesthesia, or anesthesia-delivered sedation - requiring the operating room. However, this poses significant challenges associated with operating room costs, resources, and patient wait times. Given lengthy surgical backlogs, priority is focused on more acute conditions such as malignancies that require immediate intervention. Procedures for non-acute conditions, such as penile and scrotal procedures, have wait times that can exceed six months. Since most treatment for penile and scrotal cases tends to be surgical intervention, delays in these procedures may significantly negatively impact patients' sexual health, relationships, mental health, and quality of life. The ability to perform these procedures outside of the operating room using local anesthesia with or without conscious sedation may significantly reduce patient wait times and the costs of surgical intervention. Furthermore, the use of conscious sedation would allow for faster post-operative recovery, shorter procedural times, and decreased risks/side effects associated with general anesthesia.

Fields such as plastic surgery have successfully transitioned certain procedures into a clinic- based setting and the field of urology had also shown a similar interest. The investigators research team has been at the forefront of this transition - previously demonstrating the efficacy of distal ureteroscopy under nursing administered conscious sedation and other common urologic procedures. However, these studies were limited as they did not examine invasive scrotal and penile procedures, which have an extraordinary impact on the sexual health of patients.

Significance:

This project will provide evidence on the efficacy and characteristics of successful penile and scrotal procedures conducted under the administration of local anesthesia with or without conscious sedation. The findings of this study will help transition additional urological procedures into a clinic-based setting safely: improving the sexual and mental health of patients while decreasing cost, wait times, procedure duration, recovery times, and anesthetic-related complications.

Methods:

The proposed study is a prospective study. Eligible patients at the Manitoba Men's Health Clinic (Winnipeg, MB, Canada) will be approached for potential enrollment. Procedures with or without conscious sedation are routinely performed at this clinic with volumes of 15-20 procedures performed weekly.

Patients will be approached individually for potential recruitment into the study. Prior to their urological procedure, patients will be seen by a member of the research team to determine if they are willing to participate in the study. These meetings will occur in the pre-operative waiting room at the Manitoba Men's Health Clinic where a member of the research team who is involved in the care of that patient, will review the medical chart to ensure the candidate meets the inclusion and exclusion criteria of the study. After discussing the study, potential participants will have the opportunity to decide whether they would like to be involved or not. Those who choose to be involved in the study will have to sign an informed consent form. Patients may withdraw consent and terminate participation at any time.

Each participant will be assigned a study number to track them over time. Electronic data forms will be used to collect preliminary information for all patients who consent to the study. Baseline variables for collection will include patient age, sex, BMI, co-morbidities, medications, smoking/drinking/illicit substance use, and family history of notable diseases. Clinical variables collected will include procedure side (where applicable), medication dose used for sedation, quantity and type of local anesthetic, procedural and recovery times, patient-reported and surgeon-reported visual analogue scale pre-, intra-, and post-operation.

The statistical tests will include univariable and multivariable analyses. All the variables defined above in the data collection section will be analyzed to determine if there is an association between any of these variables and the patient-reported outcomes after the urological procedure. Normally distributed continuous data will be reported as the mean ± the standard deviation. Non-normally distributed data will be presented using the median and the interquartile range. Multivariable adjusted logistic regression analysis will be used to assess predictors of whether a patient would opt for conscious sedation again as opposed to general/spinal anesthesia. SPSS Version 24.0 (SPSS Inc, IBM, Chicago, IL) will be used for data analysis.

Personal Health Information Act (PHIA) compliance of the investigators database will be ensured by preventing unauthorized access and implementing security measures such as password protecting the electronic database and never permanently storing the database on a mobile device or flash drive. Data will only be stored on the desktop computer enclosed in the Manitoba Men's Health Clinic. Database information will only be emailed using a password- protected, encrypted file. Information presented at meetings and conferences will be de- identified and anonymous. The Research Ethics Board has approved this study at the University of Manitoba.

Being tested
Conscious sedation
Keywords
Conscious sedation, Local anesthesia, Penile, Scrotal, Patient reported outcomes
Medical subject headings
Testicular Hydrocele, Spermatocele, Varicocele, Testicular Diseases, Penile Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conscious sedationOther

    Conscious sedation is a combination of medications to help you relax (a sedative, for example nitrous gas) and to block out pain (commonly known as freezing, for example lidocaine).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient reported tolerability

    Patient tolerability as assessed using a standardized questionnaire administered to patients. Key questions of interest are if patients would opt for conscious sedation for a repeat procedure or general anesthesia, recommend conscious sedation to a friend undergoing a similar procedure, and a scale question with self-reported tolerability ranging from 0-10 with a higher value corresponding to an excellent experience.

    Measured: Standardized questionnaire will be administered to patients 4-6 weeks after their individual procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2022
  2. Study start13 Nov 2022 (estimated)
  3. Primary completion1 Jun 2023 (estimated)
  4. Study completion1 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05617261
Sponsor's protocol ID
HS25658 (B2022:092)
Status last verified
Nov 2022
First submitted
3 Nov 2022
Last updated
15 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Bal DS, Chung D, Urichuk M, Shah J, Fidel MG, Panchendrabose K, Sidhom K, Bard R, Nayak JG, Patel P. Utilizing Local Anesthesia Only for Penile and Scrotal Urologic Surgery: A Prospective Study on Patient Tolerability and Surgical Outcomes for a Sedation-free Option. Urology. 2024 Dec;194:7-13. doi: 10.1016/j.urology.2024.08.051. Epub 2024 Aug 28.

    PubMed 39208947

Questions about this trial

What is this clinical trial studying?

An observational study of Hydrocele and Spermatocele, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient reported tolerability (time frame: Standardized questionnaire will be administered to patients 4-6 weeks after their individual procedure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05617261, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in